Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2014 2
2018 2
2021 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean alessandro venanzi (4 results)?
Overlapping features of therapy-related and de novo NPM1-mutated AML.
Othman J, Meggendorfer M, Tiacci E, Thiede C, Schlenk R, Dillon R, Stasik S, Venanzi A, Bertoli S, Delabesse E, Dumas PY, Pigneux A, Bidet A, Gilkes AF, Thomas I, Voso MT, Rambaldi A, Brunetti L, Perriello VM, Andresen V, Gjertsen BT, Martelli MP, Récher C, Röllig C, Bornhäuser M, Serve H, Müller-Tidow C, Baldus CD, Haferlach T, Russell N, Falini B. Othman J, et al. Among authors: venanzi a. Blood. 2023 Apr 13;141(15):1846-1857. doi: 10.1182/blood.2022018108. Blood. 2023. PMID: 36508705 Free article.
One disease, two faces: clonally-related AML and MPDCP with skin involvement.
Martino G, Cimino G, Caridi M, Perta G, Cardinali V, Sciabolacci S, Quintini M, Matteucci C, Venanzi A, Tiacci E, Ascani S, Mecucci C, Martelli MP. Martino G, et al. Among authors: venanzi a. Ann Hematol. 2023 Oct;102(10):2969-2971. doi: 10.1007/s00277-023-05377-1. Epub 2023 Jul 22. Ann Hematol. 2023. PMID: 37481474 No abstract available.
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients.
Venanzi A, Marra A, Schiavoni G, Milner SG, Limongello R, Santi A, Pettirossi V, Ultimo S, Tasselli L, Pucciarini A, Falini L, Sciabolacci S, Martelli MP, Sportoletti P, Ascani S, Falini B, Tiacci E. Venanzi A, et al. Blood Cancer Discov. 2021 May;2(3):216-225. doi: 10.1158/2643-3230.BCD-20-0203. Epub 2021 Apr 10. Blood Cancer Discov. 2021. PMID: 34164626 Free PMC article.
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.
Tiacci E, Ladewig E, Schiavoni G, Penson A, Fortini E, Pettirossi V, Wang Y, Rosseto A, Venanzi A, Vlasevska S, Pacini R, Piattoni S, Tabarrini A, Pucciarini A, Bigerna B, Santi A, Gianni AM, Viviani S, Cabras A, Ascani S, Crescenzi B, Mecucci C, Pasqualucci L, Rabadan R, Falini B. Tiacci E, et al. Among authors: venanzi a. Blood. 2018 May 31;131(22):2454-2465. doi: 10.1182/blood-2017-11-814913. Epub 2018 Apr 12. Blood. 2018. PMID: 29650799 Free PMC article.
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML.
Gionfriddo I, Brunetti L, Mezzasoma F, Milano F, Cardinali V, Ranieri R, Venanzi A, Pierangeli S, Vetro C, Spinozzi G, Dorillo E, Wu HC, Berthier C, Ciurnelli R, Griffin MJ, Jennings CE, Tiacci E, Sportoletti P, Falzetti F, de Thé H, Veal GJ, Martelli MP, Falini B. Gionfriddo I, et al. Among authors: venanzi a. Leukemia. 2021 Sep;35(9):2552-2562. doi: 10.1038/s41375-021-01192-7. Epub 2021 Mar 2. Leukemia. 2021. PMID: 33654209 Free PMC article. Clinical Trial.
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor.
Pettirossi V, Venanzi A, Spanhol-Rosseto A, Schiavoni G, Santi A, Tasselli L, Naccari M, Pensato V, Pucciarini A, Martelli MP, Drexler H, Falini B, Tiacci E. Pettirossi V, et al. Among authors: venanzi a. Leukemia. 2023 Feb;37(2):473-477. doi: 10.1038/s41375-022-01788-7. Epub 2023 Jan 12. Leukemia. 2023. PMID: 36635390 No abstract available.
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.
Martelli MP, Rossi R, Venanzi A, Meggendorfer M, Perriello VM, Martino G, Spinelli O, Ciurnelli R, Varasano E, Brunetti L, Ascani S, Quadalti C, Cardinali V, Mezzasoma F, Gionfriddo I, Milano F, Pacini R, Tabarrini A, Bigerna B, Albano F, Specchia G, Vetro C, Di Raimondo F, Annibali O, Avvisati G, Rambaldi A, Falzetti F, Tiacci E, Sportoletti P, Haferlach T, Haferlach C, Falini B. Martelli MP, et al. Among authors: venanzi a. Blood. 2021 Dec 23;138(25):2696-2701. doi: 10.1182/blood.2021012732. Blood. 2021. PMID: 34343258 Free PMC article.
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial.
Tiacci E, De Carolis L, Simonetti E, Merluzzi M, Bennati A, Perriello VM, Pucciarini A, Santi A, Venanzi A, Pettirossi V, Schiavoni G, Tasselli L, Ascani S, Volpetti S, Falini B. Tiacci E, et al. Among authors: venanzi a. Leukemia. 2021 Nov;35(11):3314-3318. doi: 10.1038/s41375-021-01210-8. Epub 2021 Mar 17. Leukemia. 2021. PMID: 33731847 Free PMC article. Clinical Trial. No abstract available.
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis.
Falini L, Venanzi A, Tini V, Innocente A, Ballanti S, Saldi S, Sivolella S, Pierini A, Aristei C, Tiacci E, Perriello VM, Falini B. Falini L, et al. Among authors: venanzi a. Haematologica. 2023 Jan 1;108(1):290-294. doi: 10.3324/haematol.2022.281351. Haematologica. 2023. PMID: 35899391 Free PMC article. No abstract available.
16 results